ONIDA, FRANCESCO
ONIDA, FRANCESCO
Dipartimento di Oncologia ed Emato-Oncologia
A case of aggressive systemic mastocytosis with bulky lymphadenopathy showing response to midostaurin
2021 M. Sciume, F. Serpenti, S. Muratori, V. Pravettoni, F.M. Ulivieri, G.A. Croci, A.C. Migliorini, A. Esposito, M.C. Goldaniga, G.N. Saporiti, G. Galassi, L. Baldini, F. Onida, F.I. Grifoni
A case of chronic mylomonocytic leukemia progressing from dysplastic to proliferative phenotype after acquisition of a RAS point mutation
2005 C. Ricci, F. Onida, E. Fermo, E. Rovida, F. Servida, A. Cortelezzi, G. Lambertenghi Deliliers, D. Soligo
A New Clinically-Based Subclassification Proposal in CMML with Significant Prognostic Implications to Overcome the MDS/MPN Categorizing Dilemma
2016 F. Onida, S. Iacobelli, G. Garcia-Manero, M. M Patnaik, R. Itzykson, T.L. Lasho, A. Nazha, R.K. Rampal, M. Eugenio Sanchez, E.J. Jabbour, N. H Al Ali, Z. Thompson, S. Colla, P. Fenaux, H.M. Kantarjian, S. Killick, S. A Mikkael, A.F. List, R.S. Komrokji, A. Tefferi, E. Solary and Eric Padron
A phase II, multicentre trial of decitabine in higher-risk chronic myelomonocytic leukemia
2018 S. V, A. B, B. Zini, G. D, D. Lunghi, M. Poloni, C. D, S. A, M. E, C. M, A. O, T. A, A. E, F. C, C. Onida, P. A, F. D, D. Saglio, F. M, L. A
A prospective phase II study on tandem autografting-nonmyeloablative allografting for newly diagnosed multiple myeloma : final results of a multicenter GITMO (Gruppo Italiano Trapianto Midollo Osseo) protocol
2007 R. Sorasio, F. Patriarca, L. Giaccone, D. Mattei, B. Allione, F. Carnevale Schianca, A. Rambaldi, M. Casini, V. Montefusco, M. Parma, P. Bavaro, F. Onida, A. Busca, L. Castagna, A.P. Iori, M. Rotta, F. Fiore, E. Benedetti, N. Mordini, M. Massaia, A. Palumbo, M. Aglietta, A. Lewis, R. Foà, P. Di Bartolomeo, E. Pogliani, G. Lambertenghi-Deliliers, M. Falda, M. Petrini, P. Corradini, R. Fanin, U. Ricardi, G. Ciccone, I. Baldi, B. Bruno, M. Boccadoro
A prospective phase II study on tandem autografting-nonmyeloablative allografting for newly diagnosed myeloma : final results of the Gruppo Italiano Trapianto Midollo Osseo
2007 B. Bruno, M. Rotta, F. Patriarca, D. Mattei, B. Allione, F. Carnevale Schianca, A. Rambaldi, M. Casini, V. Montefusco, M. Parma, P. Bavaro, F. Onida, A. Busca, L. Castagna, M.P. Iori, D. Maloney, B. Sandmaier, F. Benedetti, N. Mordini, L. Giaccone, R. Sorasio, F. Fiore, A. Filippi, A. Palumbo, M. Aglietta, A. Levis, R. Foà, P. Di Bartolomeo, E. Pogliani, G. Lambertenghi-Deliliers, M. Falda, M. Petrini, P. Corradini, R. Fanin, U. Ricardi, R. Storb, I. Baldi, M. Boccadoro
A retrospective analysis of mantle cell lymphoma patients series treated upfront by sequential high dose immunochemotherapy supported by in vivo purged stem celle double autologous transplantation: a monocentric experience
2011 A. Ferrario, G. Saporiti, N. Orofino, F. Onida, D. Vincenti, C. Basilico, F. Rossi, B. Olivero, M. Goldaniga, E. Tagliaferri, C. Annaloro, L. Baldini
A salvage intensive protocol for reinduction of CR in pre- and post- BMT phase
1999 C. Annaloro, F. Onida, E. Pozzoli, A. Della Volpe, D. Soligo, G. Lambertenghi Deliliers
Acquired in-vitro resistance to STI571 (Imatinib mesylate) in BCR/ABL-positive cell lines: investigation of gene expression by molecular pathway microarrays
2001 F. Onida, B. Scappini, H.M. Kantarjian, C. Ricci, S.R. Gatto, S. Verstovsek, K. Coombes, S.J. Lee, W. Zhang, M.J. Keating, M. Beran
Acquired platelet dysfunction and overproduction of platelet cyclic AMP in two patients with myeloid malignancies
2019 A. Lecchi, E.A. Femia, S. La Marca, F. Onida, A. Artoni
Acquisition of a RAS point mutation in a patients with chronic myelomonocytic leukemia after progression from dysplastic to proliferative variant
2005 C. Ricci, F. Onida, E. Fermo, F. Servida, A. Cortelezzi, G. Lambertenghi Deliliers, D. Soligo
Activity of sphingosine kinase inhibitor in Chronic Myelogenous Leukemia cells sensitive and resistant to Imatinib Mesylate
2008 C. Ricci, R. Ghidoni, F. Servida, G. Saporiti, G. Lambertenghi Deliliers, F. Onida
Allogeneic haematopoietic cell transplantation for chronic lymphocytic leukaemia with 17p Deletion: a retrospective EBMT analysis.
2008 J. Schetelig, A. Van Biezen, R. Brand, D. Caballero, R. Martino, M. Itala, J. Garcia Marco, L. Volin, N. Schmitz, R. Schwerdtfeger, A. Ganser, F. Onida, B. Mohr, S. Stilgenbauer, M. Bornhäuser, T. De Witte, P. Dreger
Allogeneic hematopoietic cell transplantation for patients with mycosis fungoides and Sézary syndrome : a retrospective analysis of the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation
2010 D.F. Duarte, C. Canals, F. Onida, I.H. Gabriel, R. Arranz, W. Arcese, A. Ferrant, G. Kobbe, F. Narni, G.L. Deliliers, E. Olavarría, N. Schmitz, A. Sureda
Allogeneic hematopoietic stem cell transplantation for MDS and CMML : recommendations from an international expert panel
2017 T. de Witte, D. Bowen, M. Robin, L. Malcovati, D. Niederwieser, I. Yakoub Agha, G.J. Mufti, P. Fenaux, G. Sanz, R. Martino, E.P. Alessandrino, F. Onida, A. Symeonidis, J. Passweg, G. Kobbe, A. Ganser, U. Platzbecker, J. Finke, M. van Gelder, A.A. van de Loosdrecht, P. Ljungman, R. Stauder, L. Volin, H.J. Deeg, C. Cutler, W. Saber, R. Champlin, S. Giralt, C. Anasetti, N. Kröger
Allogeneic hematopoietic stem-cell transplantation for chronic lymphocytic leukemia with 17p deletion : a retrospective European Group for Blood and Marrow Transplantation analysis
2008 J. Schetelig, A. van Biezen, R. Brand, D. Caballero, R. Martino, M. Itala, J.A. García-Marco, L. Volin, N. Schmitz, R. Schwerdtfeger, A. Ganser, F. Onida, B. Mohr, S. Stilgenbauer, M. Bornhäuser, T. de Witte, P. Dreger
Allogeneic stem cell transplantation for myelodysplastic syndromes with bone marrow fibrosis
2011 N. Kroger, T. Zabelina, A. van Biezen, R. Brand, C. Niederwieser, R. Martino, Z.Y. Lim, F. Onida, C. Schmid, L. Garderet, M. Robin, M. van Gelder, R. Marks, A. Symeonidis, G. Kobbe, T. De Witte
Allogeneic Stem Cell Transplantation for Relapsed/Refractory B-Cell Lymphomas: Results of a Multicenter Phase II Prospective Trial Including Rituximab in the Reduced Intensity Conditioning Regimen
2017 A. Dodero, F. Patriarca, G. Milone, B. Sarina, R. Miceli, A. Iori, F. Barretta, E. Terruzzi, A. Mussetti, M. Pini, A. Bosi, A. Dominietto, N. Cascavilla, F. Onida, F. Narni, L. Farina, A. Rambaldi, P. Corradini
Allogeneic stem cell transplantation in patients with atypical chronic myeloid leukaemia : a retrospective study from the chronic malignancies working party of the European society for blood and marrow transplantation
2017 F. Onida, L.C. de Wreede, A. van Biezen, D. Eikema, J.L. Byrne, A.P. Iori, R. Schots, A. Jungova, J. Schetelig, J. Finke, H. Veelken, J. Johansson, C. Craddock, M. Stelljes, M. Theobald, E. Holler, U. Schanz, N. Schaap, J. Bittenbring, E. Olavarria, Y. Chalandon, N. Kröger
Allogeneic transplantation : a therapeutic option for myelofibrosis, chronic myelomonocytic leukemia and Philadelphia-negative/BCR-ABL-negative chronic myelogenous leukemia
2004 P. Mittal, R.M. Saliba, S.A. Giralt, M. Shahajahan, A.I. Coehn, S. Karandish, F. Onida, M. Beran, R.E. Champlin, M. De Lima